Pentosan Polysulfate-A "Better Heparin" as Potential Medication for the Treatment of SARS-CoV-2 Infections?
Thromb Haemost
.
2022 Jun;122(6):870.
doi: 10.1055/a-1815-2142.
Epub 2022 Apr 1.
Author
Gerd Bendas
1
Affiliation
1
Department of Pharmacy, University of Bonn, Bonn, Germany.
PMID:
35373312
DOI:
10.1055/a-1815-2142
No abstract available
MeSH terms
COVID-19 Drug Treatment*
Heparin / adverse effects
Humans
Pentosan Sulfuric Polyester* / therapeutic use
SARS-CoV-2
Substances
Pentosan Sulfuric Polyester
Heparin